Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines Read more about Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines47 views
Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study Read more about Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study32 views
ATAGI Targeted Review 2021: the national COVID-19 vaccination program Read more about ATAGI Targeted Review 2021: the national COVID-19 vaccination program61 views
Key lessons from the COVID-19 public health response in Australia Read more about Key lessons from the COVID-19 public health response in Australia25 views
Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients Read more about Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients11 views
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19 Read more about Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-1933 views
The epidemiology of the COVID-19 pandemic in the small, low-resource country of Timor-Leste, January 2020 – June 2022 Read more about The epidemiology of the COVID-19 pandemic in the small, low-resource country of Timor-Leste, January 2020 – June 202235 views
Effect of persuasive messaging about COVID-19 vaccines for 5-11 year old children on parent intention to vaccinate Read more about Effect of persuasive messaging about COVID-19 vaccines for 5-11 year old children on parent intention to vaccinate45 views
Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia Read more about Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia27 views
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19 Read more about Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-1915 views
